Switch to:
Allergan PLC (NYSE:AGN)
EV/EBITDA
73.06 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Allergan PLC's enterprise value is $160,355 Mil. Allergan PLC's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Jun. 2015 was $2,195 Mil. Therefore, Allergan PLC's EV/EBITDA ratio for today is 73.06.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Allergan PLC's stock price is $293.74. Allergan PLC's earnings per share for the trailing twelve months (TTM) ended in Jun. 2015 was $-9.36. Therefore, Allergan PLC's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Allergan PLC's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=160354.634/2194.8
=73.06

Allergan PLC's current Enterprise Value is $160,355 Mil.
Allergan PLC's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Jun. 2015 was -80.4 (Sep. 2014 ) + 270.9 (Dec. 2014 ) + 464.5 (Mar. 2015 ) + 1539.8 (Jun. 2015 ) = $2,195 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Allergan PLC's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=293.74/-9.359
=

Allergan PLC's share price for today is $293.74.
Allergan PLC's Earnings Per Share for the trailing twelve months (TTM) ended in Jun. 2015 was -3.95 (Sep. 2014 ) + -2.759 (Dec. 2014 ) + -1.85 (Mar. 2015 ) + -0.8 (Jun. 2015 ) = $-9.36.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Allergan PLC Annual Data

Mar05Mar06Mar07Mar08Mar09Mar10Mar11Mar12Mar13Mar14
ev2ebitda 0.000.000.000.000.000.000.000.000.0038.12

Allergan PLC Quarterly Data

Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15Jun15
ev2ebitda 20.9142.8638.6257.9738.1222.0748.4554.35124.9274.73
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK